Kanya Rajangam
Pres. & Chief Med. & Dev. Off. · Senti Biosciences, Inc.
Individual
- 2024
- Mar 11, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Kanya Rajangam. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BAYER HEALTHCARE LLC - SNTI
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kanya Rajangam?
Kanya Rajangam is a corporate insider, tracked as Pres. & Chief Med. & Dev. Off. of Senti Biosciences, Inc. (SNTI). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kanya Rajangam last file a Form 4?
The most recent primary Form 4 on record is dated 11 March 2026, one of 3 filings going back to 2024.
